Jump to content

4-Methylthioethylamphetamine

From Wikipedia, the free encyclopedia

MTEA
Clinical data
Drug classserotonin reuptake inhibitor; monoamine oxidase inhibitor
ATC code
  • none
Identifiers
  • N-Ethyl-1-[4-(methylsulfanyl)phenyl]propan-2-amine
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC12H19NS
Molar mass209.35 g·mol−1
3D model (JSmol)
  • CCNC(C)CC1=CC=C(C=C1)SC
  • InChI=1S/C12H19NS/c1-4-13-10(2)9-11-5-7-12(14-3)8-6-11/h5-8,10,13H,4,9H2,1-3H3
  • Key:LAWDOCPCCFOXQO-UHFFFAOYSA-N

4-Methylthioethylamphetamine (4-MTEA) is a moderately potent serotonin reuptake inhibitor and a moderately potent reversible monoamine oxidase A inhibitor from the substituted amphetamine family; it is either an N-ethyl derivative of amphetamine or an N-ethylamfetamine derivative with an ethylthio group at the 4-position of the benzene ring.[1][2][3]

Pharmacology

[edit]

Pharmacodynamics

[edit]

MTEA acts as a monoamine reuptake inhibitor; at least, it is known to moderately inhibit the serotonin transporter with an IC50 value of 0.963 ± 0.076 µM (963 nM), which in the study indicated an inhibitory potency nearly equal to that of 3,4-methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine, although no human or animal studies have been conducted to confirm its empathogenic effect.[1] MTEA acts as a moderate-potency reversible monoamine oxidase А inhibitor with an IC50 value of 1.80 ± 0.24 µM and no effect on MAO-B.[2][3]

References

[edit]
  1. 1 2 Cloonan SM, Keating JJ, Butler SG, Knox AJ, Jørgensen AM, Peters GH, et al. (December 2009). "Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents". European Journal of Medicinal Chemistry. 44 (12): 4862–4888. doi:10.1016/j.ejmech.2009.07.027. hdl:2262/32166. PMID 19717215.
  2. 1 2 Hurtado-Guzmán C, Fierro A, Iturriaga-Vásquez P, Sepúlveda-Boza S, Cassels BK, Reyes-Parada M (August 2003). "Monoamine oxidase inhibitory properties of optical isomers and N-substituted derivatives of 4-methylthioamphetamine". Journal of Enzyme Inhibition and Medicinal Chemistry. 18 (4): 339–347. doi:10.1080/1475636031000118437. PMID 14567549.
  3. 1 2 Reyes-Parada M, Iturriaga-Vasquez P, Cassels BK (2019). "Amphetamine Derivatives as Monoamine Oxidase Inhibitors". Frontiers in Pharmacology. 10 1590. Frontiers. doi:10.3389/fphar.2019.01590. PMC 6989591. PMID 32038257.